EMA Authorised: Tygacil (tigecycline) — Pfizer Europe MA EEIG

View source ↗

Summary

The European Medicines Agency authorised Tygacil (tigecycline) for use in bacterial infections, including complicated skin and soft tissue infections and compli…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Complicated Intra-abdominal Infection
• Complicated Skin and Soft Tissue Infection

Drugs mentioned

• TYGACIL (tigecycline)

Snippet

Status: Authorised. Therapeutic area: Bacterial Infections;Skin Diseases, Bacterial;Soft Tissue Infections. MAH: Pfizer Europe MA EEIG. Decision date: 04/09/2025